Gross total resection rates in contemporary glioblastoma surgery: results of an institutional protocol combining 5-aminolevulinic acid intraoperative fluorescence imaging and brain mapping.
about
To what extent will 5-aminolevulinic acid change the face of malignant glioma surgery?Clinical utility of 5-aminolevulinic acid HCl to better visualize and more completely remove gliomas.The role of 5-aminolevulinic acid in enhancing surgery for high-grade glioma, its current boundaries, and future perspectives: A systematic review.Outcome prediction in patients with glioblastoma by using imaging, clinical, and genomic biomarkers: focus on the nonenhancing component of the tumor.Prognostic value of residual fluorescent tissue in glioblastoma patients after gross total resection in 5-aminolevulinic Acid-guided surgery.Factors associated with a higher rate of distant failure after primary treatment for glioblastoma.Neurosurgical oncology: advances in operative technologies and adjuncts.Advances in the Surgical Management of Low-Grade GliomaWhat is the Surgical Benefit of Utilizing 5-Aminolevulinic Acid for Fluorescence-Guided Surgery of Malignant Gliomas?Intraoperative fluorescence-guided resection of high-grade malignant gliomas using 5-aminolevulinic acid-induced porphyrins: a systematic review and meta-analysis of prospective studiesA phase II trial of autologous dendritic cell vaccination and radiochemotherapy following fluorescence-guided surgery in newly diagnosed glioblastoma patients.5-Aminolevulinic acid-derived tumor fluorescence: the diagnostic accuracy of visible fluorescence qualities as corroborated by spectrometry and histology and postoperative imaging.Predicting the "usefulness" of 5-ALA-derived tumor fluorescence for fluorescence-guided resections in pediatric brain tumors: a European surveyEarly re-do surgery for glioblastoma is a feasible and safe strategy to achieve complete resection of enhancing tumor.Kinetics of porphyrin fluorescence accumulation in pediatric brain tumor cells incubated in 5-aminolevulinic acid.A pilot cost-effectiveness analysis of treatments in newly diagnosed high-grade gliomas: the example of 5-aminolevulinic Acid compared with white-light surgeryFluorescence guided resection and glioblastoma in 2015: A review.Surgery for Glioblastoma: Impact of the Combined Use of 5-Aminolevulinic Acid and Intraoperative MRI on Extent of Resection and Survival.Outcomes after combined use of intraoperative MRI and 5-aminolevulinic acid in high-grade glioma surgeryRandomized, Prospective Double-Blinded Study Comparing 3 Different Doses of 5-Aminolevulinic Acid for Fluorescence-Guided Resections of Malignant Gliomas.The Value of 5-Aminolevulinic Acid in Low-grade Gliomas and High-grade Gliomas Lacking Glioblastoma Imaging Features: An Analysis Based on Fluorescence, Magnetic Resonance Imaging, 18F-Fluoroethyl Tyrosine Positron Emission Tomography, and Tumor MolSemi-Automated Volumetric and Morphological Assessment of Glioblastoma Resection with Fluorescence-Guided SurgeryAgents for fluorescence-guided glioma surgery: a systematic review of preclinical and clinical results.5-Aminolevulinic acid fluorescence in high grade glioma surgery: surgical outcome, intraoperative findings, and fluorescence patterns5-aminolevulinic acid (5-ALA) fluorescence guided surgery of high-grade gliomas in eloquent areas assisted by functional mapping. Our experience and review of the literature.Awake surgery between art and science. Part I: clinical and operative settings.The role of 5-aminolevulinic acid in brain tumor surgery: a systematic review.Various shades of red-a systematic analysis of qualitative estimation of ALA-derived fluorescence in neurosurgery.Predicting surgical outcome in patients with glioblastoma multiforme using pre-operative magnetic resonance imaging: development and preliminary validation of a grading system.Outcome of patients affected by newly diagnosed glioblastoma undergoing surgery assisted by 5-aminolevulinic acid guided resection followed by BCNU wafers implantation: a 3-year follow-up.Dexamethasone alone and in combination with desipramine, phenytoin, valproic acid or levetiracetam interferes with 5-ALA-mediated PpIX production and cellular retention in glioblastoma cells.The patients' view: impact of the extent of resection, intraoperative imaging, and awake surgery on health-related quality of life in high-grade glioma patients-results of a multicenter cross-sectional study.Combination of Fluorescence-Guided Surgery With Photodynamic Therapy for the Treatment of Cancer.5-ALA complete resections go beyond MR contrast enhancement: shift corrected volumetric analysis of the extent of resection in surgery for glioblastoma.Role of surgical resection in low- and high-grade gliomas.Maximizing safe resections: the roles of 5-aminolevulinic acid and intraoperative MR imaging in glioma surgery-review of the literature.Convection-enhanced drug delivery: prospects for glioblastoma treatment.With a Little Help from My Friends: The Role of Intraoperative Fluorescent Dyes in the Surgical Management of High-Grade Gliomas.A Phase 1 Dose-Escalation Study of Oral 5-Aminolevulinic Acid in Adult Patients Undergoing Resection of a Newly Diagnosed or Recurrent High-Grade Glioma.The Survival Advantage of "Supratotal" Resection of Glioblastoma Using Selective Cortical Mapping and the Subpial Technique.
P2860
Q27028189-2AF086E4-FB09-4324-8E13-D2EBFB039CB1Q28078505-AE91C64E-6DA6-48F1-A7B6-076832AACD41Q30250298-CA44F87F-8E1F-4E0D-8ABD-E7B22E71A1A6Q30405581-AE8B69D2-BAE6-4462-B40A-D8C21D0D3613Q30628099-AD49C125-992A-400C-9580-DB0BFBCF8036Q30679537-E768F3C6-2E95-4B87-B737-45B686A3388EQ30833619-6BB631ED-E1F8-40D1-9496-DE33025567E6Q30967374-7177E569-020C-47A3-978D-C77A731573C7Q30989894-A19CD905-ACEB-4074-AAA3-FA29C56C33ECQ31118506-6662A2B8-0E8B-4D25-BD85-87B16DE54F2AQ33668084-6754DF9E-B654-4EC3-A1C8-D1F1F7835845Q34387771-2B439B6E-6754-44EB-9310-8DA4C246B86CQ34515718-8CCDD434-FB22-4C6D-B8FD-03103D7B080DQ35069295-9FD4F448-5FED-43E5-B08F-C0E71F1106DCQ35159084-34B4D79A-291C-4B9C-A844-477087E26DECQ35542158-54F22CBB-E9FD-4AC7-8D0D-862183C6BB99Q35623174-81CB2ABA-CC15-4E14-80D1-F4B3129EE7E3Q35675842-86DF3A14-D317-4BC1-9A77-66EB4FA30D4BQ36250718-0BC52212-7E49-4A2D-AB47-10BDA4E2D3A8Q36335573-8FEA632F-D707-4934-986C-6E861395A170Q36564218-BAD7754F-031D-44EF-900A-8BD0407C7E95Q36889298-4E476FF0-3A1A-4319-82C9-127197E6DD7AQ37525571-8260D16C-637F-44A7-837A-E642A416692AQ37720272-04E4B731-94EE-4FE4-B017-C1C4CED34C7DQ38087262-628AA877-D0F7-497F-AC70-6B6D94C4AB72Q38153944-C2F50926-0D23-4F18-A12F-765CC5049D6BQ38713218-22BB27B4-7710-464C-8396-0134FAC5B98AQ38844368-17EFE77A-ABAB-4C0E-842C-CDCEFCC285CCQ39138096-1C6EAA31-CA43-441B-8072-B8C94B2C30B7Q39273311-43A6B349-015F-477C-B164-49944BB7B0B8Q40235966-89DF1F39-6375-47C9-BC4E-73A6962FF443Q40305570-B33FE9E5-86A0-4A49-81B8-B66297587233Q41591581-C008ABC1-CBD3-4F63-BAF2-460C5363FB7FQ44927068-9EFB61A9-62C4-480B-AF91-48332531D797Q46723190-B308B13F-EAFD-4FC0-93BF-1E22EADB3F62Q48333568-098522CA-E813-4D4A-8766-D36EA2DEDAE3Q48468678-C0A9242D-0486-400C-828D-B1B4CAECC9F8Q50133684-C12EE195-EDEB-4090-9943-1979F3FD2DA8Q50175112-EABF8194-31D5-47C6-98F0-5B605DE812A2Q50756545-C140D136-2BE9-4468-8A9B-CD2C19F1BF7C
P2860
Gross total resection rates in contemporary glioblastoma surgery: results of an institutional protocol combining 5-aminolevulinic acid intraoperative fluorescence imaging and brain mapping.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Gross total resection rates in ...... nce imaging and brain mapping.
@en
Gross total resection rates in ...... nce imaging and brain mapping.
@nl
type
label
Gross total resection rates in ...... nce imaging and brain mapping.
@en
Gross total resection rates in ...... nce imaging and brain mapping.
@nl
prefLabel
Gross total resection rates in ...... nce imaging and brain mapping.
@en
Gross total resection rates in ...... nce imaging and brain mapping.
@nl
P2093
P1433
P1476
Gross total resection rates in ...... ence imaging and brain mapping
@en
P2093
Andreas Raabe
Janine Abu-Isa
Kathleen Seidel
Lennard Stieglitz
Michael Murek
Philippe Schucht
P304
927-35; discussion 935-6
P356
10.1227/NEU.0B013E31826D1E6B
P407
P577
2012-11-01T00:00:00Z